Literature DB >> 7904442

Polyarteritis nodosa associated with streptococcus.

J David1, B M Ansell, P Woo.   

Abstract

Twelve children are described with an essentially benign vasculitic illness in association with streptococcal infection. They demonstrated characteristic clinical features of nodular cutaneous polyarteritis with fever. Laboratory findings showed an acute phase response associated with raised antistreptolysin and antihyaluronidase titres in all patients and a positive throat culture for beta haemolytic streptococcus in three patients. Ten required corticosteroids. Two patients had systemic involvement with abnormal arteriography; both had appreciably raised white cell counts (> 40 x 10(9)/l). They may represent a subset of poststreptococcal vasculitis, requiring cytotoxic treatment for effective disease control.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904442      PMCID: PMC1029656          DOI: 10.1136/adc.69.6.685

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Prognostic factors in polyarteritis.

Authors:  M Sack; J T Cassidy; G G Bole
Journal:  J Rheumatol       Date:  1975-12       Impact factor: 4.666

2.  POLYARTERITIS AND ACUTE POST-STREPTOCOCCAL GLOMERULONEPHRITIS.

Authors:  C C FORDHAM; F H EPSTEIN; W D HUFFINES; J T HARRINGTON
Journal:  Ann Intern Med       Date:  1964-07       Impact factor: 25.391

3.  CUTANEOUS FORM OF PERIARTERITIS NODOSA--AN ENTITY?

Authors:  I FISHER; M ORKIN
Journal:  Arch Dermatol       Date:  1964-02

4.  Polyarteritis nodosa.

Authors:  G A ROSE; H SPENCER
Journal:  Q J Med       Date:  1957-01

5.  Polyarteritis presenting with leg pains.

Authors:  D N Golding
Journal:  Br Med J       Date:  1970-01-31

6.  Cutaneous polyarteritis nodosa.

Authors:  P Borrie
Journal:  Br J Dermatol       Date:  1972-08       Impact factor: 9.302

7.  Vasculitis.

Authors:  C W Fink
Journal:  Pediatr Clin North Am       Date:  1986-10       Impact factor: 3.278

8.  A syndrome of childhood polyarteritis.

Authors:  D B Magilavy; R E Petty; J T Cassidy; D B Sullivan
Journal:  J Pediatr       Date:  1977-07       Impact factor: 4.406

  8 in total
  13 in total

Review 1.  Clinical management and treatment of vasculitis.

Authors:  D Jayne
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Pediatric vasculitis.

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 3.  Coexistence of vasculitides with familial Mediterranean fever.

Authors:  Kenan Aksu; Gokhan Keser
Journal:  Rheumatol Int       Date:  2011-03-10       Impact factor: 2.631

Review 4.  Pediatric vasculitis.

Authors:  Pamela F Weiss
Journal:  Pediatr Clin North Am       Date:  2012-04-06       Impact factor: 3.278

Review 5.  Vasculitis from the pediatric perspective.

Authors:  P A Brogan; M J Dillon
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.686

6.  Cutaneous polyarteritis nodosa in childhood: a case report and review of the literature.

Authors:  Nina-Karen Bansal; Kristin Michelle Houghton
Journal:  Arthritis       Date:  2010-11-24

Review 7.  Cutaneous polyarteritis nodosa successfully treated with topical diflucortolone valerate: a case report & review of the literature.

Authors:  Ruby Haviv; Maya Capua; Jacob Amir; Liora Harel
Journal:  Pediatr Rheumatol Online J       Date:  2014-10-10       Impact factor: 3.054

8.  Chronic polyarthritis as the first manifestation of childhood systemic polyarteritis nodosa.

Authors:  Glaucia Vanessa Novak; Koken Hayashi; Kohei Sampa; Yosuke Okumura; Gabriela Ribeiro Viola Ferreira; Clovis Artur Silva
Journal:  Einstein (Sao Paulo)       Date:  2017 Jan-Mar

Review 9.  Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction.

Authors:  Yusuke Kanda; Mitsuhiko Osaki; Futoshi Okada
Journal:  Int J Mol Sci       Date:  2017-04-19       Impact factor: 5.923

Review 10.  Medium-size-vessel vasculitis.

Authors:  Michael J Dillon; Despina Eleftheriou; Paul A Brogan
Journal:  Pediatr Nephrol       Date:  2009-11-28       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.